TRRAPtransformation/transcription domain associated protein
Autism Reports / Total Reports
8 / 18Rare Variants / Common Variants
63 / 0Aliases
TRRAP, PAF350/400, PAF400, STAF40, TR-AP, Tra1Associated Syndromes
-Chromosome Band
7q22.1Associated Disorders
ASDRelevance to Autism
A de novo loss-of-function variant and multiple de novo missense variants in the TRRAP gene have been observed in ASD probands (Iossifov et al., 2014; Yuen et al., 2017), while multiple de novo missense variants in this gene have also been identified in probands with unspecified developmental disorders (Deciphering Developmental Disorders Study 2017) or epilepsy (Epi4K Consortium 2013). An integrated meta-analysis of de novo mutation data from a combined dataset of 10,927 individuals with neurodevelopmental disorders identified TRRAP as a gene with an excess of missense variants (false discovery rata < 5%, count >1) (Coe et al., 2018). Cogne et al., 2019 reported 24 individuals with 17 distinct de novo or apparently de novo missense variants that presented with two distinct clinical spectra: the first was a complex multi-systemic syndrome associated with various malformations of the brain, heart, kidneys and genitourinary system and a wide range of intellectual functioning in individuals with variants clustered between animo acids 1031 and 1159; the second spectrum manifested with autism spectrum disorder and/or intellectual disability and epilepsy in individuals with variants outside of this region.
Molecular Function
This gene encodes a large multidomain protein of the phosphoinositide 3-kinase-related kinases (PIKK) family. The encoded protein is a common component of many histone acetyltransferase (HAT) complexes and plays a role in transcription and DNA repair by recruiting HAT complexes to chromatin.
External Links
SFARI Genomic Platforms
Reports related to TRRAP (18 Reports)
# | Type | Title | Author, Year | Autism Report | Associated Disorders |
---|---|---|---|---|---|
1 | Support | De novo mutations in epileptic encephalopathies | Epi4K Consortium , et al. (2013) | No | - |
2 | Primary | The contribution of de novo coding mutations to autism spectrum disorder | Iossifov I et al. (2014) | Yes | - |
3 | Support | Prevalence and architecture of de novo mutations in developmental disorders | et al. (2017) | No | - |
4 | Support | Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder | C Yuen RK et al. (2017) | Yes | - |
5 | Support | De novo variant of TRRAP in a patient with very early onset psychosis in the context of non-verbal learning disability and obsessive-compulsive disorder: a case report | Mavros CF , et al. (2018) | No | - |
6 | Recent Recommendation | Neurodevelopmental disease genes implicated by de novo mutation and copy number variation morbidity | Coe BP , et al. (2018) | No | - |
7 | Support | Inherited and multiple de novo mutations in autism/developmental delay risk genes suggest a multifactorial model | Guo H , et al. (2018) | Yes | - |
8 | Recent Recommendation | Missense Variants in the Histone Acetyltransferase Complex Component Gene TRRAP Cause Autism and Syndromic Intellectual Disability | Cogn B , et al. (2019) | No | ASD |
9 | Support | De Novo Damaging DNA Coding Mutations Are Associated With Obsessive-Compulsive Disorder and Overlap With Tourette's Disorder and Autism | Cappi C , et al. (2019) | No | - |
10 | Support | - | Li D et al. (2022) | Yes | - |
11 | Support | - | Zhou X et al. (2022) | Yes | - |
12 | Recent Recommendation | - | Pollina EA et al. (2023) | No | - |
13 | Support | - | Cirnigliaro M et al. (2023) | Yes | - |
14 | Support | - | Sheth F et al. (2023) | Yes | DD, ID |
15 | Support | - | Kirsten Furley et al. () | No | ASD |
16 | Support | - | Ruohao Wu et al. (2024) | Yes | - |
17 | Support | - | Miriam E Reyna-Fabián et al. (2024) | No | DD, epilepsy/seizures |
18 | Support | - | Axel Schmidt et al. (2024) | No | ASD |
Rare Variants (63)
Status | Allele Change | Residue Change | Variant Type | Inheritance Pattern | Parental Transmission | Family Type | PubMed ID | Author, Year |
---|---|---|---|---|---|---|---|---|
c.3311A>G | p.Glu1104Gly | missense_variant | De novo | - | - | 28135719 | et al. (2017) | |
c.3337G>A | p.Val1113Met | missense_variant | De novo | - | - | 28135719 | et al. (2017) | |
c.4634C>T | p.Ala1545Val | missense_variant | De novo | - | - | 28135719 | et al. (2017) | |
c.5596T>A | p.Trp1866Arg | missense_variant | De novo | - | - | 28135719 | et al. (2017) | |
c.5598G>T | p.Trp1866Cys | missense_variant | De novo | - | - | 28135719 | et al. (2017) | |
c.7697C>G | p.Ala2566Gly | missense_variant | De novo | - | - | 28135719 | et al. (2017) | |
c.9300+4C>T | - | splice_region_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.10096C>G | p.His3366Asp | missense_variant | De novo | - | - | 28135719 | et al. (2017) | |
c.52A>T | p.Met18Leu | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.68A>G | p.Gln23Arg | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.6G>A | p.Ala2%3D | synonymous_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.2386G>C | p.Gly796Arg | missense_variant | Unknown | - | - | 34968013 | Li D et al. (2022) | |
c.8477+1G>A | - | splice_site_variant | Unknown | - | - | 38536866 | Kirsten Furley et al. () | |
c.1116G>T | p.Arg372Ser | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.2320C>A | p.Leu774Ile | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.2769C>G | p.Ser923Arg | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.5786C>T | p.Pro1929Leu | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.11261C>T | p.Thr3754Ile | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.3127G>A | p.Ala1043Thr | missense_variant | De novo | - | - | 30827496 | Cogn B , et al. (2019) | |
c.6415T>C | p.Trp2139Arg | missense_variant | De novo | - | - | 30827496 | Cogn B , et al. (2019) | |
c.5280C>T | p.Phe1760%3D | synonymous_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.6904C>A | p.Arg2302Ser | synonymous_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
c.6011G>A | p.Arg2004Gln | missense_variant | De novo | - | - | 30424743 | Mavros CF , et al. (2018) | |
c.2087G>A | p.Arg696His | missense_variant | Unknown | - | Simplex | 30564305 | Guo H , et al. (2018) | |
c.5692A>G | p.Lys1898Glu | missense_variant | De novo | - | - | 39039281 | Axel Schmidt et al. (2024) | |
c.8432A>C | p.Lys2811Thr | missense_variant | Unknown | - | - | 39039281 | Axel Schmidt et al. (2024) | |
c.2413C>T | p.Leu805Phe | missense_variant | De novo | - | Simplex | 30827496 | Cogn B , et al. (2019) | |
c.2580C>G | p.Phe860Leu | missense_variant | De novo | - | Simplex | 30827496 | Cogn B , et al. (2019) | |
c.2678G>T | p.Arg893Leu | missense_variant | De novo | - | Simplex | 30827496 | Cogn B , et al. (2019) | |
c.3093T>G | p.Ile1031Met | missense_variant | De novo | - | Simplex | 30827496 | Cogn B , et al. (2019) | |
c.3104G>A | p.Arg1035Gln | missense_variant | De novo | - | Simplex | 30827496 | Cogn B , et al. (2019) | |
c.3127G>A | p.Ala1043Thr | missense_variant | De novo | - | Simplex | 30827496 | Cogn B , et al. (2019) | |
c.3311A>G | p.Glu1104Gly | missense_variant | De novo | - | Simplex | 30827496 | Cogn B , et al. (2019) | |
c.3331G>T | p.Gly1111Trp | missense_variant | De novo | - | Simplex | 30827496 | Cogn B , et al. (2019) | |
c.3475G>A | p.Gly1159Arg | missense_variant | De novo | - | Simplex | 30827496 | Cogn B , et al. (2019) | |
c.4465G>A | p.Asp1489Asn | missense_variant | De novo | - | Simplex | 30827496 | Cogn B , et al. (2019) | |
c.5596T>A | p.Trp1866Arg | missense_variant | De novo | - | Simplex | 30827496 | Cogn B , et al. (2019) | |
c.5598G>T | p.Trp1866Cys | missense_variant | De novo | - | Simplex | 30827496 | Cogn B , et al. (2019) | |
c.5647G>A | p.Gly1883Arg | missense_variant | De novo | - | Simplex | 30827496 | Cogn B , et al. (2019) | |
c.9529G>A | p.Val3177Met | missense_variant | Unknown | - | Simplex | 37543562 | Sheth F et al. (2023) | |
c.310G>A | p.Glu104Lys | missense_variant | De novo | - | Simplex | 28263302 | C Yuen RK et al. (2017) | |
c.5576G>A | p.Arg1859His | missense_variant | De novo | - | Simplex | 31771860 | Cappi C , et al. (2019) | |
c.2446C>T | p.Arg816Trp | missense_variant | De novo | - | Simplex | 38764027 | Ruohao Wu et al. (2024) | |
c.3316G>A | p.Glu1106Lys | missense_variant | De novo | - | Multiplex | 30827496 | Cogn B , et al. (2019) | |
c.3652G>A | p.Ala1218Thr | missense_variant | De novo | - | Simplex | 28263302 | C Yuen RK et al. (2017) | |
c.1195G>A | p.Val399Ile | missense_variant | De novo | - | Simplex | 25363768 | Iossifov I et al. (2014) | |
c.5575C>T | p.Arg1859Cys | missense_variant | De novo | - | Simplex | 25363768 | Iossifov I et al. (2014) | |
c.11461C>T | p.Arg3821Cys | missense_variant | De novo | - | Simplex | 25363768 | Iossifov I et al. (2014) | |
c.3761C>A | p.Ser1254Tyr | missense_variant | Familial | Paternal | Simplex | 30564305 | Guo H , et al. (2018) | |
c.7090C>T | p.Leu2364Phe | missense_variant | Familial | Paternal | Simplex | 30564305 | Guo H , et al. (2018) | |
c.5592C>G | p.Phe1864Leu | missense_variant | De novo | - | Multiplex | 37506195 | Cirnigliaro M et al. (2023) | |
c.10775C>G | p.Ser3592Cys | missense_variant | Familial | Maternal | Simplex | 30564305 | Guo H , et al. (2018) | |
c.2575G>A | p.Asp859Asn | missense_variant | Unknown | - | Multi-generational | 30827496 | Cogn B , et al. (2019) | |
c.5795C>T | p.Pro1932Leu | missense_variant | Familial | Maternal | Multiplex | 30827496 | Cogn B , et al. (2019) | |
c.3111C>A | p.Ser1037Arg | missense_variant | De novo | - | Multi-generational | 30827496 | Cogn B , et al. (2019) | |
c.5647G>A | p.Gly1883Arg | missense_variant | De novo | - | Multi-generational | 30827496 | Cogn B , et al. (2019) | |
c.11270G>A | p.Arg3757Gln | missense_variant | De novo | - | Simplex | 23934111 | Epi4K Consortium , et al. (2013) | |
c.3316G>A | p.Glu1106Lys | missense_variant | Unknown | Not maternal | Simplex | 30827496 | Cogn B , et al. (2019) | |
c.11270G>A | p.Arg3757Gln | missense_variant | De novo | - | Extended multiplex | 30827496 | Cogn B , et al. (2019) | |
c.3127G>A | p.Ala1043Thr | missense_variant | Unknown | - | Simplex | 38909058 | Miriam E Reyna-Fabián et al. (2024) | |
c.6110_6112del | p.Met2037_Asp2038delinsAsn | inframe_deletion | De novo | - | Simplex | 35982159 | Zhou X et al. (2022) | |
c.7950_7951insAGATAAG | p.Glu2651ArgfsTer2 | frameshift_variant | De novo | - | Simplex | 28263302 | C Yuen RK et al. (2017) | |
c.4250_4254del | p.Thr1417ArgfsTer43 | frameshift_variant | Familial | Maternal | Multiplex | 37506195 | Cirnigliaro M et al. (2023) |
Common Variants
No common variants reported.
SFARI Gene score
Strong Candidate, Syndromic
A de novo loss-of-function variant and multiple de novo missense variants in the TRRAP gene have been observed in ASD probands (Iossifov et al., 2014; Yuen et al., 2017), while multiple de novo missense variants in this gene have also been identified in probands with unspecified developmental disorders (Deciphering Developmental Disorders Study 2017) or epilepsy (Epi4K Consortium 2013). An integrated meta-analysis of de novo mutation data from a combined dataset of 10,927 individuals with neurodevelopmental disorders identified TRRAP as a gene with an excess of missense variants (false discovery rata < 5%, count >1) (Coe et al., 2018). Cogne et al., 2019 reported 24 individuals with 17 distinct de novo or apparently de novo missense variants that presented with two distinct clinical spectra: the first was a complex multi-systemic syndrome associated with various malformations of the brain, heart, kidneys and genitourinary system and a wide range of intellectual functioning in individuals with variants clustered between animo acids 1031 and 1159; the second spectrum manifested with autism spectrum disorder and/or intellectual disability and epilepsy in individuals with variants outside of this region.
Score Delta: Score remained at 2S
criteria met
See SFARI Gene'scoring criteriaWe considered a rigorous statistical comparison between cases and controls, yielding genome-wide statistical significance, with independent replication, to be the strongest possible evidence for a gene. These criteria were relaxed slightly for category 2.
The syndromic category includes mutations that are associated with a substantial degree of increased risk and consistently linked to additional characteristics not required for an ASD diagnosis. If there is independent evidence implicating a gene in idiopathic ASD, it will be listed as "#S" (e.g., 2S, 3S, etc.). If there is no such independent evidence, the gene will be listed simply as "S."
4/1/2022
Decreased from 3S to 2S
Description
A de novo loss-of-function variant and multiple de novo missense variants in the TRRAP gene have been observed in ASD probands (Iossifov et al., 2014; Yuen et al., 2017), while multiple de novo missense variants in this gene have also been identified in probands with unspecified developmental disorders (Deciphering Developmental Disorders Study 2017) or epilepsy (Epi4K Consortium 2013). An integrated meta-analysis of de novo mutation data from a combined dataset of 10,927 individuals with neurodevelopmental disorders identified TRRAP as a gene with an excess of missense variants (false discovery rata < 5%, count >1) (Coe et al., 2018). Cogne et al., 2019 reported 24 individuals with 17 distinct de novo or apparently de novo missense variants that presented with two distinct clinical spectra: the first was a complex multi-systemic syndrome associated with various malformations of the brain, heart, kidneys and genitourinary system and a wide range of intellectual functioning in individuals with variants clustered between animo acids 1031 and 1159; the second spectrum manifested with autism spectrum disorder and/or intellectual disability and epilepsy in individuals with variants outside of this region.
1/1/2020
Decreased from 3S to 3S
Description
A de novo loss-of-function variant and multiple de novo missense variants in the TRRAP gene have been observed in ASD probands (Iossifov et al., 2014; Yuen et al., 2017), while multiple de novo missense variants in this gene have also been identified in probands with unspecified developmental disorders (Deciphering Developmental Disorders Study 2017) or epilepsy (Epi4K Consortium 2013). An integrated meta-analysis of de novo mutation data from a combined dataset of 10,927 individuals with neurodevelopmental disorders identified TRRAP as a gene with an excess of missense variants (false discovery rata < 5%, count >1) (Coe et al., 2018). Cogne et al., 2019 reported 24 individuals with 17 distinct de novo or apparently de novo missense variants that presented with two distinct clinical spectra: the first was a complex multi-systemic syndrome associated with various malformations of the brain, heart, kidneys and genitourinary system and a wide range of intellectual functioning in individuals with variants clustered between animo acids 1031 and 1159; the second spectrum manifested with autism spectrum disorder and/or intellectual disability and epilepsy in individuals with variants outside of this region.
10/1/2019
Decreased from 4S to 3S
New Scoring Scheme
Description
A de novo loss-of-function variant and multiple de novo missense variants in the TRRAP gene have been observed in ASD probands (Iossifov et al., 2014; Yuen et al., 2017), while multiple de novo missense variants in this gene have also been identified in probands with unspecified developmental disorders (Deciphering Developmental Disorders Study 2017) or epilepsy (Epi4K Consortium 2013). An integrated meta-analysis of de novo mutation data from a combined dataset of 10,927 individuals with neurodevelopmental disorders identified TRRAP as a gene with an excess of missense variants (false discovery rata < 5%, count >1) (Coe et al., 2018). Cogne et al., 2019 reported 24 individuals with 17 distinct de novo or apparently de novo missense variants that presented with two distinct clinical spectra: the first was a complex multi-systemic syndrome associated with various malformations of the brain, heart, kidneys and genitourinary system and a wide range of intellectual functioning in individuals with variants clustered between animo acids 1031 and 1159; the second spectrum manifested with autism spectrum disorder and/or intellectual disability and epilepsy in individuals with variants outside of this region.
Reports Added
[New Scoring Scheme]1/1/2019
Increased from to 4S
Description
A de novo loss-of-function variant and multiple de novo missense variants in the TRRAP gene have been observed in ASD probands (Iossifov et al., 2014; Yuen et al., 2017), while multiple de novo missense variants in this gene have also been identified in probands with unspecified developmental disorders (Deciphering Developmental Disorders Study 2017) or epilepsy (Epi4K Consortium 2013). An integrated meta-analysis of de novo mutation data from a combined dataset of 10,927 individuals with neurodevelopmental disorders identified TRRAP as a gene with an excess of missense variants (false discovery rata < 5%, count >1) (Coe et al., 2018). Cogne et al., 2019 reported 24 individuals with 17 distinct de novo or apparently de novo missense variants that presented with two distinct clinical spectra: the first was a complex multi-systemic syndrome associated with various malformations of the brain, heart, kidneys and genitourinary system and a wide range of intellectual functioning in individuals with variants clustered between animo acids 1031 and 1159; the second spectrum manifested with autism spectrum disorder and/or intellectual disability and epilepsy in individuals with variants outside of this region.
Krishnan Probability Score
Score 0.49167643518953
Ranking 5259/25841 scored genes
[Show Scoring Methodology]
ExAC Score
Score 1
Ranking 6/18225 scored genes
[Show Scoring Methodology]
Iossifov Probability Score
Score 0.999
Ranking 5/239 scored genes
[Show Scoring Methodology]
Sanders TADA Score
Score 0.75043382725747
Ranking 1559/18665 scored genes
[Show Scoring Methodology]
Zhang D Score
Score 0.4270510239026
Ranking 1152/20870 scored genes
[Show Scoring Methodology]